{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:42:47Z","timestamp":1794472967252,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["CCMU2022ZKYXZ009"],"award-info":[{"award-number":["CCMU2022ZKYXZ009"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["L222123"],"award-info":[{"award-number":["L222123"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["QML20230505"],"award-info":[{"award-number":["QML20230505"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["xuekegugan-02-47"],"award-info":[{"award-number":["xuekegugan-02-47"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3600400"],"award-info":[{"award-number":["2022YFC3600400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3600600"],"award-info":[{"award-number":["2022YFC3600600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eclinm.2023.102357","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T19:15:28Z","timestamp":1701544528000},"page":"102357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4351-2877","authenticated-orcid":false,"given":"Anxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eclinm.2023.102357_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.eclinm.2023.102357_bib3","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMc2027491","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Kaushik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.eclinm.2023.102357_bib4","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA","volume":"385","author":"Wang","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.eclinm.2023.102357_bib5","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.eclinm.2023.102357_bib6","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation","volume":"51","author":"Brunzell","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102357_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102357_bib8","article-title":"Remnant lipoprotein cholesterol and incident coronary heart disease: the jackson heart and framingham offspring cohort studies","volume":"5","author":"Joshi","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102357_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/ATVBAHA.117.310269","article-title":"Nonfasting triglycerides, low-density lipoprotein cholesterol, and heart failure risk: two cohort studies of 113 554 individuals","volume":"38","author":"Varbo","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.eclinm.2023.102357_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","article-title":"Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality","volume":"44","author":"Wadstr\u00f6m","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102357_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOL.0000000000000093","article-title":"Remnant cholesterol and ischemic heart disease","volume":"25","author":"Varbo","year":"2014","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102357_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.eclinm.2023.102357_bib13","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/01.CIR.0000125278.58527.F3","article-title":"Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype","volume":"109","author":"Twickler","year":"2004","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.eclinm.2023.102357_bib14","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102357_bib16","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","article-title":"Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a mendelian randomization study","volume":"43","author":"Navarese","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"42","key":"10.1016\/j.eclinm.2023.102357_bib17","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5551\/jat.E598","article-title":"Remnant lipoproteins as strong key particles to atherogenesis","volume":"16","author":"Fujioka","year":"2009","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102357_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5551\/jat.RV16003","article-title":"Postprandial hyperlipidemia and remnant lipoproteins","volume":"24","author":"Masuda","year":"2017","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.thromres.2004.08.029","article-title":"Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents","volume":"115","author":"Yamazaki","year":"2005","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102357_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5114\/aoms.2018.81035","article-title":"Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy","volume":"15","author":"J\u00e4ger","year":"2019","journal-title":"Arch Med Sci"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0049-3848(95)00116-9","article-title":"Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability","volume":"79","author":"Orth","year":"1995","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102357_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0049-3848(96)00033-3","article-title":"The in\u00a0vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons","volume":"81","author":"Mochizuki","year":"1996","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102357_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/svn-2020-000791","article-title":"Clopidogrel with aspirin in High-risk patients with acute non-disabling cerebrovascular events II (CHANCE-2): rationale and design of a multicentre randomised trial","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102357_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.26287","article-title":"Bleeding risk of dual antiplatelet therapy after minor stroke or transient ischemic attack","volume":"91","author":"Wang","year":"2022","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/biostatistics\/kxh002","article-title":"Patterns of treatment effects in subsets of patients in clinical trials","volume":"5","author":"Bonetti","year":"2004","journal-title":"Biostatistics"},{"issue":"19","key":"10.1016\/j.eclinm.2023.102357_bib28","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO;2-M","article-title":"A\u00a0graphical method to assess treatment-covariate interactions using the cox model on subsets of the data","volume":"19","author":"Bonetti","year":"2000","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102357_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/sim.3524","article-title":"A\u00a0small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data","volume":"28","author":"Bonetti","year":"2009","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102357_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/ejhf.2221","article-title":"Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial","volume":"23","author":"Voors","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102357_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13059","article-title":"Contribution of remnant cholesterol to cardiovascular risk","volume":"288","author":"Langsted","year":"2020","journal-title":"J\u00a0Intern Med"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102357_bib32","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/metabo12100898","article-title":"The level of remnant cholesterol and implications for lipid-lowering strategy in hospitalized patients with acute coronary syndrome in China: findings from the improving care for cardiovascular disease in China-acute coronary syndrome project","volume":"12","author":"Yang","year":"2022","journal-title":"Metabolites"},{"issue":"9567","key":"10.1016\/j.eclinm.2023.102357_bib33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.eclinm.2023.102357_bib34","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.eclinm.2023.102357_bib35","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102357_bib36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacl.2023.03.009","article-title":"Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization","volume":"17","author":"Zafrir","year":"2023","journal-title":"J\u00a0Clin Lipidol"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102357_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014116","article-title":"Remnant cholesterol and the risk of coronary artery calcium progression: insights from the CARDIA and MESA study","volume":"15","author":"Hao","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102357_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102357_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.25432","article-title":"Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population","volume":"85","author":"Varbo","year":"2019","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102357_bib40","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102357_bib41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","article-title":"Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans","volume":"37","author":"Bernelot Moens","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"47","key":"10.1016\/j.eclinm.2023.102357_bib42","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:02Z","timestamp":1762899722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023005345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":42,"alternative-id":["S2589537023005345"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102357","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102357"}}